24 Hours Urinary Phosphorous

Kidney

Report in 4Hrs

At Home

No Fasting Required

Details

Assesses total phosphorus excretion in urine collected over 24 hours.

₹148₹211

30% OFF

24 Hours Urinary Phosphorous

Why is it done?
- Measures the total amount of phosphorus excreted in urine over a 24-hour period to assess phosphorus metabolism and kidney function
- Evaluates mineral and bone metabolism disorders, particularly in patients with abnormal serum phosphorus levels
- Assists in diagnosing and monitoring chronic kidney disease, hyperparathyroidism, and hypoparathyroidism
- Investigates causes of hypercalcemia and hypophosphatemia
- Monitors patients on renal replacement therapy or those with bone-related disorders requiring phosphorus level optimization
- Typically performed when serum phosphorus levels are abnormal or when evaluating disorders of phosphorus homeostasis
Normal Range
- Reference Range: 400-1300 mg/24 hours (or 12.9-42.0 mmol/24 hours)
- Units of Measurement: milligrams per 24 hours (mg/24h) or millimoles per 24 hours (mmol/24h)
- Normal Result Interpretation: Indicates normal phosphorus excretion and appropriate kidney handling of serum phosphorus; consistent with normal mineral metabolism
- Low Values (Below 400 mg/24h): May indicate increased renal phosphorus reabsorption, hypoparathyroidism, or inadequate dietary phosphorus intake
- High Values (Above 1300 mg/24h): May suggest hyperparathyroidism, vitamin D excess, kidney disease, or increased dietary phosphorus intake
- Note: Reference ranges may vary by laboratory and population; always consult specific laboratory guidelines
Interpretation
- Elevated Urinary Phosphorus (>1300 mg/24h):
  - Suggests primary or secondary hyperparathyroidism with increased PTH-mediated phosphorus wasting
  - May indicate vitamin D intoxication causing phosphaturia
  - Can reflect high dietary phosphorus intake or excessive supplementation
  - May be associated with renal tubular dysfunction or early-stage kidney disease
- Decreased Urinary Phosphorus (<400 mg/24h):
  - Indicates hypoparathyroidism or pseudohypoparathyroidism with enhanced renal phosphorus reabsorption
  - May suggest adequate kidney function with low filtered phosphorus load
  - Can reflect dietary phosphorus deficiency or severe malabsorption
  - May indicate advanced chronic kidney disease with phosphorus retention
- Factors Affecting Results:
  - Dietary phosphorus intake (major variable affecting results)
  - PTH and vitamin D levels regulating phosphorus reabsorption
  - FGF23 (fibroblast growth factor 23) affecting tubular phosphorus handling
  - Medications including phosphate binders, corticosteroids, and diuretics
  - Acid-base status affecting renal handling of electrolytes
  - Presence of concurrent kidney, bone, or metabolic diseases
- Clinical Significance:
  - Combined with serum phosphorus, calcium, and PTH, helps differentiate primary PTH disorders from secondary causes
  - Assesses fractional excretion of phosphorus (FEPhos) to evaluate tubular function
  - Essential for monitoring patients on hemodialysis or peritoneal dialysis
  - Guides therapeutic interventions for phosphorus balance optimization
Associated Organs
- Primary Organ Systems Involved:
  - Kidneys - primary regulators of urinary phosphorus excretion through glomerular filtration and tubular reabsorption
  - Parathyroid glands - produce PTH regulating renal phosphorus handling and serum levels
  - Bones - phosphorus homeostasis essential for bone mineralization and structure
  - Small intestine - site of dietary phosphorus absorption
- Medical Conditions Associated with Abnormal Results:
  - Primary hyperparathyroidism (increased urinary phosphorus)
  - Secondary hyperparathyroidism from chronic kidney disease
  - Hypoparathyroidism and pseudohypoparathyroidism (decreased urinary phosphorus)
  - Chronic kidney disease and end-stage renal disease
  - Vitamin D intoxication (increased urinary phosphorus)
  - Renal tubular acidosis and other renal tubular disorders
  - Hypophosphatemic rickets and hypophosphatasia
  - Malignancy-related hypercalcemia and phosphaturia
  - Thyroid disorders affecting mineral metabolism
- Potential Complications with Abnormal Results:
  - Elevated urinary phosphorus leading to hypophosphatemia and increased fracture risk
  - Decreased urinary phosphorus resulting in phosphorus retention and hyperphosphatemia
  - Secondary hyperparathyroidism and renal osteodystrophy in chronic kidney disease
  - Vascular calcification and soft tissue mineralization from phosphorus imbalance
  - Nephrolithiasis from excessive urinary phosphorus and calcium excretion
  - Neurological complications from severe electrolyte imbalances
Follow-up Tests
- Recommended Follow-up Tests Based on Results:
  - Serum phosphorus and calcium (simultaneous evaluation for complete assessment)
  - Intact parathyroid hormone (PTH) to assess parathyroid function
  - 25-hydroxy vitamin D and 1,25-dihydroxy vitamin D for vitamin D status evaluation
  - 24-hour urinary calcium to assess calcium-phosphorus homeostasis
  - Creatinine clearance and serum creatinine for kidney function assessment
  - FGF23 (fibroblast growth factor 23) for phosphate regulating hormone assessment
  - Alkaline phosphatase and bone-specific alkaline phosphatase for bone metabolism markers
- Further Investigations:
  - Dual-energy X-ray absorptiometry (DEXA) scan for bone density if osteoporosis suspected
  - Imaging studies (ultrasound or CT) if parathyroid adenoma or kidney stones suspected
  - Urinalysis and urine electrolytes for comprehensive renal assessment
  - Parathyroid imaging (sestamibi scan or ultrasound) if hyperparathyroidism confirmed
- Monitoring Frequency for Ongoing Conditions:
  - Chronic kidney disease patients: every 3-6 months for mineral metabolism monitoring
  - Dialysis patients: monthly or as per dialysis protocol for phosphorus control
  - Parathyroid disease patients: baseline and 6-12 weeks after treatment initiation
  - Post-parathyroidectomy: 6 weeks and then yearly for recurrence monitoring
  - Bone disease patients: baseline and then as clinically indicated
- Complementary Tests:
  - Fractional excretion of phosphorus (FEPhos) calculation for tubular function assessment
  - Serum magnesium and potassium for complete electrolyte panel
  - Phosphorus-calcium product assessment for tissue calcification risk
Fasting Required?
- Fasting Required: No - fasting is not required for 24-hour urinary phosphorus collection
- Special Instructions for Collection:
  - Discard first morning void; note this exact time as the start of 24-hour collection
  - Collect all urine for exactly 24 hours, including final void the following morning
  - Use sterile, clean container provided by the laboratory (usually contains preservative)
  - Keep container refrigerated or on ice during collection period
  - Record total urine volume and collection start/end times on container label
  - Transport specimen to laboratory immediately after collection completion
- Dietary Considerations:
  - Patient should maintain normal dietary phosphorus intake during collection period
  - Avoid significant dietary changes during 24-hour collection to ensure accurate results
  - Normal hydration and fluid intake should be maintained as usual
- Medications to Consider:
  - Do not discontinue regular medications unless specifically instructed by physician
  - Inform laboratory of medications affecting mineral metabolism (thiazide diuretics, corticosteroids, vitamin D supplements)
  - Report phosphate binders or other phosphorus-related medications to healthcare provider
- Additional Patient Preparation:
  - Patient education on proper collection technique to prevent contamination
  - Avoid contamination from toilet paper, stool, or menstrual blood in females
  - Ensure all 24-hour collection is captured; incomplete collection may invalidate results
  - Contact laboratory with any questions or if collection is incomplete

How our test process works!